zileuton has been researched along with Cardiac Remodeling, Ventricular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Z; Chen, JJ; Deng, W; Duan, M; Guo, Y; Liu, C; Tang, Q; Wang, J; Wu, QQ; Xiao, Y; Xie, S; Yuan, Y | 1 |
1 other study(ies) available for zileuton and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
The 5-Lipoxygenase Inhibitor Zileuton Protects Pressure Overload-Induced Cardiac Remodeling via Activating PPAR
Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyurea; Lipoxygenase Inhibitors; Male; Mice; Myocytes, Cardiac; NF-E2-Related Factor 2; PPAR alpha; Rats; Signal Transduction; Ventricular Remodeling | 2019 |